30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cytodyn Inc (CYDY)

Track

Stock chart
Ticker: CYDY Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Mulholland Michael D.
Chief Financial Officer
3 sales — total 4,437,557 USD
Sale 22 Dec 2020
Value US$1,019,807.17 | Price 350.14 | Shares 22,129
Sale 22 Dec 2020
Value US$1,814,414.61 | Price 354.91 | Shares 2,548
Planned sale 22 Dec 2020
Value US$1,349,848.64 | Price 5.49 | Shares 245,704
Sale 21 Dec 2020
Value US$786,493.67 | Price 124.78 | Shares 20,717
Sale 18 Dec 2020
Value US$2,411,439.10 | Price 4.95 | Shares 487,002
Planned sale 17 Dec 2020
Value US$145,673.60 | Price 4.55 | Shares 32,000
Buy 2 Nov 2020
Value US$497,295.00 | Price 2.57 | Shares 193,500
Buy 23 Oct 2020
Value US$298,308.00 | Price 2.49 | Shares 120,000
Buy 23 Oct 2020
Value US$25,000.00 | Price 2.50 | Shares 10,000
Sale 4 May 2020
Value US$3,353,089.74 | Price 2.79 | Shares 1,201,652
Sale 1 May 2020
Value US$3,912,480.00 | Price 3.26 | Shares 1,200,000
Buy 1 May 2020
Value US$141,250.00 | Price 0.57 | Shares 250,000
Sale 1 May 2020
Value US$4,569,131.71 | Price 3.26 | Shares 1,399,685
Sale 30 Apr 2020
Value US$7,838,688.41 | Price 3.53 | Shares 2,219,837
Buy 21 Oct 2016
Value US$9,930.00 | Price 0.66 | Shares 15,000
Buy 17 Oct 2016
Value US$7,238.00 | Price 0.66 | Shares 11,000
Buy 5 Jun 2015
Value US$18,345.00 | Price 0.50 | Shares 36,690
Buy 5 Jun 2015
Value US$18,345.00 | Price 0.50 | Shares 36,690
Buy 5 May 2015
Value US$52,076.50 | Price 0.50 | Shares 104,153
Buy 5 May 2015
Value US$52,076.50 | Price 0.50 | Shares 104,153
Buy 30 Oct 2014
Value US$18,720.00 | Price 0.72 | Shares 26,000
Buy 15 Oct 2014
Value US$1,975.00 | Price 0.79 | Shares 2,500
Sale 20 Sep 2012
Value US$50,700.00 | Price 0.78 | Shares 65,000
Sale 19 Sep 2012
Value US$8,300.00 | Price 0.83 | Shares 10,000
Sale 7 May 2012
Value US$14,493.50 | Price 2.02 | Shares 7,175
Sale 2 May 2012
Value US$3,000.00 | Price 2.00 | Shares 1,500
Sale 1 May 2012
Value US$24,858.63 | Price 2.07 | Shares 12,009
Sale 24 Jan 2012
Value US$81,300.00 | Price 2.71 | Shares 30,000
Buy 21 Dec 2011
Value US$75,000.00 | Price 1.50 | Shares 50,000
Sale 15 Jan 2010
Value US$579.00 | Price 1.93 | Shares 300
Sale 11 Jan 2010
Value US$9,750.00 | Price 1.95 | Shares 5,000
Sale 6 Jan 2010
Value US$7,635.60 | Price 1.80 | Shares 4,242
Sale 5 Jan 2010
Value US$2,492.00 | Price 1.78 | Shares 1,400
Sale 4 Jan 2010
Value US$8,750.00 | Price 1.75 | Shares 5,000
Sale 29 Dec 2009
Value US$4,321.33 | Price 1.69 | Shares 2,557
Sale 22 Dec 2009
Value US$830.00 | Price 1.66 | Shares 500
Sale 13 Nov 2009
Value US$150,000.00 | Price 0.50 | Shares 300,000
Sale 26 Oct 2009
Value US$9,240.00 | Price 1.32 | Shares 7,000
Sale 23 Oct 2009
Value US$7,384.55 | Price 1.13 | Shares 6,535
Sale 22 Oct 2009
Value US$3,085.50 | Price 1.10 | Shares 2,805
Sale 19 Oct 2009
Value US$1,878.12 | Price 1.08 | Shares 1,739
Sale 16 Oct 2009
Value US$19,318.80 | Price 1.02 | Shares 18,940
Buy 1 Oct 2009
Value US$655,200.00 | Price 0.90 | Shares 728,000
Sale 30 Sep 2009
Value US$194,376.00 | Price 0.27 | Shares 728,000
Sale 29 Sep 2009
Value US$2,425.00 | Price 0.97 | Shares 2,500
Sale 28 Sep 2009
Value US$6,422.40 | Price 0.96 | Shares 6,690
Sale 25 Sep 2009
Value US$19,569.60 | Price 0.81 | Shares 24,160
Sale 24 Sep 2009
Value US$5,004.00 | Price 0.72 | Shares 6,950
Sale 23 Sep 2009
Value US$1,474.00 | Price 0.67 | Shares 2,200
Sale 21 Sep 2009
Value US$5,696.00 | Price 0.64 | Shares 8,900
Sale 18 Sep 2009
Value US$593.37 | Price 0.57 | Shares 1,041
Buy 1 Jul 2009
Value US$303,200.00 | Price 0.50 | Shares 606,400
Buy 25 Jun 2009
Value US$1,460,808.04 | Price 0.62 | Shares 2,356,142
Sale 25 Jun 2009
Value US$2,356,000.00 | Price 23.56 | Shares 100,000
Sale 22 May 2009
Value US$2,000.00 | Price 0.80 | Shares 2,500
Sale 2 Feb 2009
Value US$171,360.00 | Price 0.08 | Shares 2,040,000
Sale 19 Jun 2008
Value US$3,825.00 | Price 0.51 | Shares 7,500
Sale 2 Jun 2008
Value US$4,950.00 | Price 0.99 | Shares 5,000
Sale 19 May 2008
Value US$2,500.00 | Price 0.50 | Shares 5,000
Buy 22 Jun 2007
Value US$650.00 | Price 0.65 | Shares 1,000
Buy 22 Jun 2007
Value US$600.00 | Price 0.60 | Shares 1,000
Buy 21 May 2007
Value US$1,375.00 | Price 0.55 | Shares 2,500
Buy 30 Jan 2007
Value US$845,000.00 | Price 8.45 | Shares 100,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-28 2020-12-22 S Sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
22,129 -4.2%
350.14
US$1,019,807 		22,129 -4.2% 350.14 US$1,019,807
2020-12-28 2020-12-22 S Sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
2,548 -20.0%
354.91
US$1,814,415 		2,548 -20.0% 354.91 US$1,814,415
2020-12-28 2020-12-22 PlS Planned sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
99,536 +6.0%
375.25
US$4,113,672 		99,536 +6.0% 375.25 US$4,113,672
2020-12-21 2020-12-21 S Sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
589,797 -67.5%
5.58
US$3,292,247 		589,797 -67.5% 5.58 US$3,292,247
2020-12-21 2020-12-18 S Sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
487,002 -63.2%
4.95
US$2,411,439 		487,002 -63.2% 4.95 US$2,411,439
2020-12-21 2020-12-17 PlS Planned sale
3.4
Mulholland Michael D.

Chief Financial Officer

Officer
32,000 -10.1%
4.55
US$145,674 		32,000 -10.1% 4.55 US$145,674
2020-11-03 2020-11-02 B Purchase
3.1
Naydenov Jordan G
Non-Executive Director
193,500 +3.1%
2.57
US$497,295 		193,500 +3.1% 2.57 US$497,295
2020-10-26 2020-10-23 B Purchase
3.1
Naydenov Jordan G
Non-Executive Director
120,000 +2.0%
2.49
US$298,308 		120,000 +2.0% 2.49 US$298,308
2020-10-26 2020-10-23 B Purchase
3.2
Colachis Arian

GC and Corporate Secretary

Officer
10,000 +14.3%
2.50
US$25,000 		10,000 +14.3% 2.50 US$25,000
2020-05-04 2020-05-04 S Sale
2.0
Pourhassan Nader

President & CEO

Executive Director
1,201,652 -57.0%
2.79
US$3,353,090 		1,201,652 -57.0% 2.79 US$3,353,090
2020-05-05 2020-05-01 S Sale
1.6
Kelly Scott A.

Chief Medical Officer

Executive Director
1,200,000 -43.5%
3.26
US$3,912,480 		1,200,000 -43.5% 3.26 US$3,912,480
2020-05-05 2020-05-01 B Purchase
1.6
Kelly Scott A.

Chief Medical Officer

Executive Director
250,000 +15.7%
0.57
US$141,250 		250,000 +15.7% 0.57 US$141,250
2020-05-04 2020-05-01 S Sale
2.0
Pourhassan Nader

President & CEO

Executive Director
1,399,685 -40.2%
3.26
US$4,569,132 		1,399,685 -40.2% 3.26 US$4,569,132
2020-05-04 2020-04-30 S Sale
2.0
Pourhassan Nader

President & CEO

Executive Director
2,219,837 -39.0%
3.53
US$7,838,688 		2,219,837 -39.0% 3.53 US$7,838,688
2016-10-21 2016-10-21 B Purchase Pourhassan Nader

President and CEO

Executive Director
15,000 +2000.0%
0.66
US$9,930 		15,000 +2000.0% 0.66 US$9,930
2016-10-17 2016-10-17 B Purchase Mulholland Michael D.

CFO, Treasurer and Secretary

Officer
11,000 +42.2%
0.66
US$7,238 		11,000 +42.2% 0.66 US$7,238
2015-07-20 2015-06-05 B Purchase ALPHA ADVISORS, LLC

Indirect

Large shareholder
36,690 +1.7%
0.50
US$18,345 		36,690 +1.7% 0.50 US$18,345
2015-07-15 2015-06-05 B Purchase DOCKERY CARL Non-Executive Director Large shareholder
36,690 +1.7%
0.50
US$18,345 		36,690 +1.7% 0.50 US$18,345
2015-07-20 2015-05-05 B Purchase ALPHA ADVISORS, LLC

Indirect

Large shareholder
104,153 +5.0%
0.50
US$52,076 		104,153 +5.0% 0.50 US$52,076
2015-07-15 2015-05-05 B Purchase DOCKERY CARL Non-Executive Director Large shareholder
104,153 +5.0%
0.50
US$52,076 		104,153 +5.0% 0.50 US$52,076
2014-10-31 2014-10-30 B Purchase Caracciolo Anthony Non-Executive Director
26,000 +41.8%
0.72
US$18,720 		26,000 +41.8% 0.72 US$18,720
2014-10-16 2014-10-15 B Purchase Mulholland Michael D.

CFO, Treasurer and Secretary

Officer
2,500 +10.6%
0.79
US$1,975 		2,500 +10.6% 0.79 US$1,975
2012-09-21 2012-09-20 S Sale Dembow George F Non-Executive Director
65,000 -20.7%
0.78
US$50,700 		65,000 -20.7% 0.78 US$50,700
2012-09-21 2012-09-19 S Sale Dembow George F Non-Executive Director
10,000 -3.1%
0.83
US$8,300 		10,000 -3.1% 0.83 US$8,300
2012-05-09 2012-05-07 S Sale Dembow George F Non-Executive Director
7,175 -2.2%
2.02
US$14,494 		7,175 -2.2% 2.02 US$14,494
2012-05-03 2012-05-02 S Sale Dembow George F Non-Executive Director
1,500 -0.5%
2.00
US$3,000 		1,500 -0.5% 2.00 US$3,000
2012-05-03 2012-05-01 S Sale Dembow George F Non-Executive Director
12,009 -3.6%
2.07
US$24,859 		12,009 -3.6% 2.07 US$24,859
2012-01-25 2012-01-24 S Sale Dembow George F Non-Executive Director
30,000 -8.2%
2.71
US$81,300 		30,000 -8.2% 2.71 US$81,300
2011-12-22 2011-12-21 B Purchase CARACCIOLO ANTHONY Non-Executive Director
50,000 +inf%
1.50
US$75,000 		50,000 +inf% 1.50 US$75,000
2011-11-02 2010-01-15 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
300 -0.0%
1.93
US$579 		300 -0.0% 1.93 US$579
2011-11-02 2010-01-11 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
5,000 -0.3%
1.95
US$9,750 		5,000 -0.3% 1.95 US$9,750
2011-11-02 2010-01-06 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
4,242 -0.2%
1.80
US$7,636 		4,242 -0.2% 1.80 US$7,636
2011-11-02 2010-01-05 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
1,400 -0.1%
1.78
US$2,492 		1,400 -0.1% 1.78 US$2,492
2011-11-02 2010-01-04 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
5,000 -0.3%
1.75
US$8,750 		5,000 -0.3% 1.75 US$8,750
2011-11-02 2009-12-29 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
2,557 -0.1%
1.69
US$4,321 		2,557 -0.1% 1.69 US$4,321
2011-11-02 2009-12-22 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
500 -0.0%
1.66
US$830 		500 -0.0% 1.66 US$830
2009-11-17 2009-11-13 S Sale ALLEN ALLEN D

Chief Executive Officer

Executive Director Large shareholder
300,000 -17.6%
0.50
US$150,000 		300,000 -17.6% 0.50 US$150,000
2011-11-02 2009-10-26 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
7,000 -0.4%
1.32
US$9,240 		7,000 -0.4% 1.32 US$9,240
2011-11-02 2009-10-23 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
6,535 -0.3%
1.13
US$7,385 		6,535 -0.3% 1.13 US$7,385
2011-11-02 2009-10-22 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
2,805 -0.1%
1.10
US$3,086 		2,805 -0.1% 1.10 US$3,086
2011-11-02 2009-10-19 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
1,739 -0.1%
1.08
US$1,878 		1,739 -0.1% 1.08 US$1,878
2011-11-02 2009-10-16 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
18,940 -1.0%
1.02
US$19,319 		18,940 -1.0% 1.02 US$19,319
2011-11-02 2009-10-01 B Purchase Van Ness Kenneth

CEO & President

Executive Director Large shareholder
728,000 +inf%
0.90
US$655,200 		728,000 +inf% 0.90 US$655,200
2009-11-02 2009-09-30 S Sale UTEK CORP Large shareholder
728,000 -30.9%
0.27
US$194,376 		728,000 -30.9% 0.27 US$194,376
2011-11-02 2009-09-29 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
2,500 -0.1%
0.97
US$2,425 		2,500 -0.1% 0.97 US$2,425
2011-11-02 2009-09-28 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
6,690 -0.3%
0.96
US$6,422 		6,690 -0.3% 0.96 US$6,422
2011-11-02 2009-09-25 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
24,160 -1.2%
0.81
US$19,570 		24,160 -1.2% 0.81 US$19,570
2011-11-02 2009-09-24 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
6,950 -0.3%
0.72
US$5,004 		6,950 -0.3% 0.72 US$5,004
2011-11-02 2009-09-23 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
2,200 -0.1%
0.67
US$1,474 		2,200 -0.1% 0.67 US$1,474
2011-11-02 2009-09-21 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
8,900 -0.4%
0.64
US$5,696 		8,900 -0.4% 0.64 US$5,696
2011-11-02 2009-09-18 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
1,041 -0.1%
0.57
US$593 		1,041 -0.1% 0.57 US$593
2009-09-29 2009-07-01 B Purchase Naydenov Jordan G Non-Executive Director
606,400 +inf%
0.50
US$303,200 		606,400 +inf% 0.50 US$303,200
2009-11-02 2009-06-25 B Purchase UTEK CORP Large shareholder
2,356,142 +inf%
0.62
US$1,460,808 		2,356,142 +inf% 0.62 US$1,460,808
2009-11-02 2009-06-25 S Sale UTEK CORP Large shareholder
100,000 -100.0%
23.56
US$2,356,000 		100,000 -100.0% 23.56 US$2,356,000
2011-11-02 2009-05-22 S Sale Van Ness Kenneth

CEO & President

Executive Director Large shareholder
2,500 -0.1%
0.80
US$2,000 		2,500 -0.1% 0.80 US$2,000
2009-11-02 2009-02-02 S Sale UTEK CORP Large shareholder
2,040,000 -100.0%
0.08
US$171,360 		2,040,000 -100.0% 0.08 US$171,360
2008-06-26 2008-06-19 S Sale Dembow George F Non-Executive Director
7,500 -1.9%
0.51
US$3,825 		7,500 -1.9% 0.51 US$3,825
2008-06-26 2008-06-02 S Sale Dembow George F Non-Executive Director
5,000 -1.3%
0.99
US$4,950 		5,000 -1.3% 0.99 US$4,950
2008-06-26 2008-05-19 S Sale Dembow George F Non-Executive Director
5,000 -1.2%
0.50
US$2,500 		5,000 -1.2% 0.50 US$2,500
2007-06-27 2007-06-22 B Purchase ALLEN CORINNE E

Vice President

Executive Director Large shareholder
1,000 +0.1%
0.65
US$650 		1,000 +0.1% 0.65 US$650
2007-06-27 2007-06-22 B Purchase ALLEN CORINNE E

Vice President

Executive Director Large shareholder
1,000 +0.1%
0.60
US$600 		1,000 +0.1% 0.60 US$600
2007-05-21 2007-05-21 B Purchase ALLEN CORINNE E

Vice President

Executive Director Large shareholder
2,500 +0.2%
0.55
US$1,375 		2,500 +0.2% 0.55 US$1,375
2009-11-02 2007-01-30 B Purchase UTEK CORP Large shareholder
100,000 +inf%
8.45
US$845,000 		100,000 +inf% 8.45 US$845,000
Explore more

More insider trading research around Cytodyn Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America